Treatment Plans for Fabry Disease
13:53
FDA Approval of Setmelanotide for Patients 2 Years and Older With MC4R Pathway Diseases
4:18
Fabry Disease Patient Journey
5:24
Ozone dialysis developed by Dr Louie Yu
13:37
The evolving landscape of Primary Biliary Cholangitis (PBC): new therapies and future directions
7:54
EMA Pathway to Approval for Mavorixafor to Treat Patients with WHIM Syndrome
3:00
Determining the Best Treatment Option for Fabry Disease
25:30
10 signes avant-coureurs du cancer que vous ne devriez pas ignorer
49:13